Targeting BCL2 for the Treatment of Lymphoid Malignancies
Mary Ann Anderson, David Huang, Andrew Roberts
Seminars in Hematology | W B SAUNDERS CO-ELSEVIER INC | Published : 2014
Awarded by Australian National Health and Medical Research Council
Drs Huang and Roberts are employees of the Walter and Eliza Hall Institute of Medical Research, which receives research funding and milestone payments in relation to ABT-199. Dr Anderson is the recipient of a Webster Fellowship (Melbourne Health). Work in the laboratories of Drs Huang and Roberts is supported by an IRIISS (Independent Research Institutes Infrastructure Support Scheme) and grants (1016647, 1016701) and fellowships (637309, 1043149) from the Australian National Health and Medical Research Council, the Leukemia Lymphoma Society, the Cancer Council of Victoria, the Australian Cancer Research Foundation, the Leukaemia Foundation of Australia, and a Victorian State Government Operational Infrastructure Support grant.